Dr Sylvie Shen
Contact Details
Tabs
Publications related to this Person
Book Chapters
Dolnikov A; O'Brien TA; Xu N; Shen S; Klamer G, 2014, 'Strategies to improve immune reconstitution after haematopoeitic stem cell transplantation.', in Rahman A; Anjum S (ed.), Frontiers in Stem Cell and Regenerative Medicine Research, vol. 1, Bentham Science, pp. 30 - 64, http://dx.doi.org/10.2174/97816080599421150101
Journal articles
Ehteda A; Simon S; Franshaw L; Giorgi FM; Liu J; Joshi S; Rouaen JRC; Pang CNI; Pandher R; Mayoh C; Tang Y; Khan A; Ung C; Tolhurst O; Kankean A; Hayden E; Lehmann R; Shen S; Gopalakrishnan A; Trebilcock P; Gurova K; Gudkov AV; Norris MD; Haber M; Vittorio O; Tsoli M; Ziegler DS, 2021, 'Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG', Cell Reports, vol. 35, pp. 108994 - 108994, http://dx.doi.org/10.1016/j.celrep.2021.108994
Voli F; Valli E; Lerra L; Kimpton K; Saletta F; Giorgi FM; Mercatelli D; Rouaen JRC; Shen S; Murray JE; Ahmed-Cox A; Cirillo G; Mayoh C; Beavis PA; Haber M; Trapani JA; Kavallaris M; Vittorio O, 2020, 'Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion', Cancer Research, vol. 80, pp. 4129 - 4144, http://dx.doi.org/10.1158/0008-5472.CAN-20-0471
Shen S; Ferrell K; Chaudhry K; Vu A; Nordon R; O'Brien T, 2019, 'Modulation of anti-tumour activity of ex vivo expanded NK and GD2CAR-NK cells against neuroblastoma', Cytotherapy, vol. 21, pp. S20 - S20, http://dx.doi.org/10.1016/j.jcyt.2019.03.317
Dolnikov A; Xu N; Tse B; Shen S; O'Brien T, 2018, 'Bromodomain inhibitor jq1 modulates immune suppressive pathways in neuroblastoma and enhances CARGD2T cell therapy', Cytotherapy, vol. 20, pp. S97 - S97, http://dx.doi.org/10.1016/j.jcyt.2018.02.285
Xu N; Shen S; Dolnikov A, 2017, 'Increasing Stem Cell Dose Promotes Posttransplant Immune Reconstitution', Stem cells and development, vol. 26, pp. 461 - 470, http://dx.doi.org/10.1089/scd.2016.0186
Shen S; O'Brien T, 2017, 'Modulation of anti-tumour activity of ex vivo expanded NK cells against neuroblastoma via HDACi and PD1/PD-L1 blockade', Cytotherapy, vol. 19, pp. S13 - S14, http://dx.doi.org/10.1016/j.jcyt.2017.02.021
Dolnikov A; Yang S; Shen S; Xu N; Chaudhry K; Nordon R; O'Brien T, 2016, 'Prolonging CART Cell Persistence Using Conditioning with 5-Azacytidine', Cytotherapy, vol. 18, pp. S98 - S98, http://dx.doi.org/10.1016/j.jcyt.2016.03.201
Shen S; Xu N; Yang S; O'Brien T; Dolnikov A, 2016, 'Stem Cell Approach to Generate Chimeric Antigen Receptor Modified Immune Effector Cells to Treat Cancer', Cytotherapy, vol. 18, pp. S101 - S101, http://dx.doi.org/10.1016/j.jcyt.2016.03.211
Shen S; Dolnikov A; O'Brien T, 2016, 'Use of HDACi and PD-1/PD-L1 Blockade to Enhance Cytolytic Activity of Ex Vivo Expanded NK Cells Against Neuroblastoma', Cytotherapy, vol. 18, pp. S101 - S101, http://dx.doi.org/10.1016/j.jcyt.2016.03.212
Shen S; Xu N; Klamer G; Ko KH; Khoo M; Ma D; Moore J; O'Brien TA; Dolnikov A, 2015, 'Small-molecule inhibitor of glycogen synthase kinase 3β 6-bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice', Stem Cells and Development, vol. 24, pp. 724 - 736, http://dx.doi.org/10.1089/scd.2014.0230
Dolnikov A; Shen S; Klamer G; Joshi S; Xu N; Yang L; Micklethwaite K; O'Brien TA, 2015, 'Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia', Experimental Hematology, vol. 43, pp. 1001 - 1014.e5, http://dx.doi.org/10.1016/j.exphem.2015.08.006
Komala MG; Gross S; Mudaliar H; Huang C; Pegg K; Mather A; Shen S; Pollock CA; Panchapakesan U, 2014, 'Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic enos knockout mice', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0108994
Komala MG; Gross S; Mudaliar H; Huang C; Pegg K; Mather A; Shen S; Pollock CA; Panchapakesan U, 2014, 'Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic enos knockout mice', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0108994
Huang C; Shen S; Ma Q; Gill A; Pollock CA; Chen XM, 2014, 'KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis', Nephrology Dialysis Transplantation, vol. 29, pp. 313 - 324, http://dx.doi.org/10.1093/ndt/gft431
Dolnikov A; Xu N; Shen S; Song E; Holmes T; Klamer G; O'Brien TA, 2014, 'GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells', Cell Proliferation, vol. 47, pp. 113 - 123, http://dx.doi.org/10.1111/cpr.12092
Huang C; Shen S; Ma Q; Gill A; Pollock CA; Chen X-M, 2014, 'KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis', Nephrology Dialysis Transplantation, vol. 29, pp. 313 - 324
Cheng D; Shen S; Chen XM; Pollock C; Braet F, 2013, 'Application of transmission electron tomography for modeling the renal corpuscle', Pathology Research and Practice, vol. 209, pp. 731 - 734, http://dx.doi.org/10.1016/j.prp.2013.06.013
Yong R; Chen XM; Shen S; Vijayaraj S; Ma Q; Pollock CA; Saad S, 2013, 'Plumbagin Ameliorates Diabetic Nephropathy via Interruption of Pathways that Include NOX4 Signalling', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0073428
Huang C; Shen S; Ma Q; Chen J; Gill A; Pollock CA; Chen XM, 2013, 'Blockade of KCa3.1 ameliorates renal fibrosis through the tgf-β1/smad pathway in diabetic mice', Diabetes, vol. 62, pp. 2923 - 2934, http://dx.doi.org/10.2337/db13-0135
Tang O; Chen XM; Shen S; Hahn M; Pollock CA, 2013, 'MiRNA-200b represses transforming growth factor-β1-induced EMT and fibronectin expression in kidney proximal tubular cells', American Journal of Physiology - Renal Physiology, vol. 304, pp. 1266 - 1273, http://dx.doi.org/10.1152/ajprenal.00302.2012
Shen S; Xu N; Klamer G; O'Brien TA; Dolnikov A, 2013, 'NOVEL APPROACH TO GENERATE CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS USING GENETICALLY MODIFIED T CELL PRECURSORS', CYTOTHERAPY, vol. 15, pp. S54 - S54, http://dx.doi.org/10.1016/j.jcyt.2013.01.211
Klamer G; Shen S; Song E; Rice AM; Knight R; Lindeman R; O'Brien TA; Dolnikov A, 2013, 'GSK3 inhibition prevents lethal GVHD in mice', Experimental Hematology, vol. 41, http://dx.doi.org/10.1016/j.exphem.2012.09.005
Shen S; Xu N; O'Brien TA; Dolnikov A; Klamer G, 2013, 'GSK-3β inhibition preserves naive T cell phenotype in bone marrow reconstituted mice', Experimental Hematology, vol. 41, pp. 1016 - 1027, http://dx.doi.org/10.1016/j.exphem.2013.08.006
Mcintyre GJ; Groneman JL; Yu YH; Jaramillo A; Shen S; Applegate TL, 2009, '96 shRNAs designed for maximal coverage of HIV-1 variants', Retrovirology, vol. 6, http://dx.doi.org/10.1186/1742-4690-6-55
Mcintyre GJ; Yu Y; Tran A; Jaramillo AB; Arndt AJ; Millington ML; Boyd MP; Elliott FA; Shen SW; Murray JM; Applegate TL, 2009, 'Cassette deletion in multiple shRNA lentiviral vectors for HIV-1 and its impact on treatment success', Virology Journal, vol. 6, pp. 184, http://dx.doi.org/10.1186/1743-422X-6-184
Millington ML; Arndt A; Boyd MP; Applegate TL; Shen SW, 2009, 'Towards a clinically relevant lentiviral transduction protocol for primary human CD34 hematopoietic stem/progenitor cells', PLoS One, vol. 4, pp. e6461, http://dx.doi.org/10.1371/journal.pone.0006461
Choo A; Palladinetti P; Holmes TA; Basu S; Shen S; Lock RB; O Brien T; Symonds GP; Dolnikov A, 2008, 'siRNA targeting the IRF2 transcription factor inhibits leukaemic cell growth.', International Journal of Oncology, vol. 33, pp. 175 - 183
Holmes TA; O Brien T; Knight RJ; Lindeman R; Shen S; Song YE; Symonds GP; Dolnikov A, 2008, 'Glycogen synthase kinase-3 beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth', Stem Cells, vol. 26, pp. 1288 - 1297, http://dx.doi.org/10.1634/stemcells.2007-0600
Shen S; Passioura TJ; Symonds GP; Dolnikov A, 2007, 'N-ras oncogene-induced gene expression in human hematopoietic progenitor cells: Upregulation of p16INK4a and p21CIP1/WAF1 correlates with myeloid differentiation', Experimental Hematology, vol. 35, pp. 908 - 919, http://dx.doi.org/10.1016/j.exphem.2007.02.011
Choo A; Palladinetti P; Passioura TJ; Shen S; Symonds GP; Dolnikov A, 2006, 'The role of IRF1 and IRF2 transcription factors in leukaemogenesis', Current Gene Therapy, vol. 6, pp. 543 - 550, http://dx.doi.org/10.2174/156652306778520683
Passioura TJ; Shen S; Symonds GP; Dolnikov A, 2005, 'A retroviral library genetic screen identitifies IRF-2 as an inhabitor of N-ras induced growth suppervision in leukemai cells', Oncogene, vol. 24, pp. 7327 - 7336, http://dx.doi.org/10.1038/sj.onc.1208877
Passioura TJ; Dolnikov A; Shen S; Symonds GP, 2005, 'N-ras induced growth suppression of myeloid cells is mediated by IRF-1', Cancer research, vol. 65, pp. 797 - 804
Shen S; Passioura TJ; Choo A; Symonds GP; Dolnikov A, 2005, 'Mutant N-ras activation in primary human hemaopoietic progenitor cells: biologic, phenotypic and genetic sequelae', EJC Supplements, vol. 3, pp. 285 - 285, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000247564801146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Shen S; Passioura ; Choo A; Symonds G; Dolnikov A, 2005, 'Targeting the IRF2 transcription factor to inhibit leukaemic cell growth', Journal of Gene Medicine, vol. 7, pp. 1135 - 1135, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231477900071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Shen SC; Dolnikov A; Passioura TJ; Millington M; Wotherspoon S; Rice AM; Mackenzie K; Symonds GP, 2004, 'Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid proliferation both in vitro and in the NOd/SCID mouse.', Experimental Hematology, vol. 32, pp. 852 - 860, http://dx.doi.org/10.1016/j.exphem.2004.06.001
Dolnikov A; Shen S; Millington M; Passioura T; Pedler M; Rasko JEJ; Symonds G, 2003, 'A sensitive dual-fluorescence reporter system enables positive selection of ras suppressors by suppression of ras-induced apoptosis', Cancer Gene Therapy, vol. 10, pp. 745 - 754, http://dx.doi.org/10.1038/sj.cgt.7700603
Dolnikov A; Shen SC; Passioura TJ; Symonds GP, 2003, 'Bone marrow reconstituiton as a relevant model of genetically programmd leukemia', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, vol. 1, pp. 83 - 97, http://dx.doi.org/10.2174/1568016033477531
Dolnikov A; Shen S; Passioura TJ; Symonds GP, 2003, 'Genetic control of hematopoietic stem cell biology and leukemogenesis', Blood, vol. 102, pp. 332A - 332A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186536701194&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Conference Papers
Bishop D; Xu N; Shen S; O'Brien T; Gottlieb D; Dolnikov A; Micklethwaite K, 2017, 'Preclinical optimization of a low cost PiggyBac transposase (PB) generated CD19-specific chimeric antigen receptor T cell (CART19) product for a first in man trial using local hospital cell manufacture', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, Washington, DC, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, 01 April 2017 - 05 April 2017, http://dx.doi.org/10.1158/1538-7445.AM2017-3760
Dolnikov A; Shen S; Xu N; Yang S; O'Brien T, 2015, 'DECLINED PRESENTATION T-CELL PRECURSORS TO GENERATE CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, Kyoto, JAPAN, pp. S60 - S60, presented at 44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH), Kyoto, JAPAN, 17 September 2015 - 19 September 2015, http://dx.doi.org/10.1016/j.exphem.2015.06.110
Dolnikov A; Shen S; Xu N; Yang S; O'Brien T, 2015, 'DECLINED PRESENTATION STEM CELL APPROACH TO GENERATE CHIMERIC ANTIGEN RECEPTOR MODIFIED IMMUNE EFFECTOR CELLS', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, Kyoto, JAPAN, pp. S59 - S59, presented at 44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH), Kyoto, JAPAN, 17 September 2015 - 19 September 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000361417400091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Yang S; Shen S; Xu N; O'Brien T, 2015, 'DECLINED PRESENTATION ONE DOSE OF 5-AZA-2 '-DEOXYCYTIDINE ENHANCES THERAPEUTIC EFFICACY OF CART-CELL THERAPY IN A MURINE MODEL BY IMPROVING T-CELL PERSISTENCE', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, Kyoto, JAPAN, pp. S59 - S59, presented at 44th Annual Scientific Meeting of the International-Society-for-Experimental-Hematology (ISEH), Kyoto, JAPAN, 17 September 2015 - 19 September 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000361417400092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Rossi S; Xu N; Klamer G; Shen S; Micklethwaite KP; Lock RB; O'Brien T, 2014, '5-Aza-2 '-Deoxycytidine Promotes Cytotoxic Effect of CART-Cells on Leukaemia Cells', in BLOOD, AMER SOC HEMATOLOGY, San Francisco, CA, presented at 56th Annual Meeting of the American-Society-of-Hematology, San Francisco, CA, 06 December 2014 - 09 December 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349233806021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Chitranjan A; Shen S; Klamer G; O'Brien T, 2014, 'TESTING CAR-T CELL ACTIVITY IN HUMAN HEMATOCHIMERIC MOUSE MODEL WITH THE NORMAL RANGE OF ANTIGEN EXPRESSION NOT RESCTRICTED TO THE TUMOUR ONLY', in CYTOTHERAPY, ELSEVIER SCI LTD, pp. S23 - S23, http://dx.doi.org/10.1016/j.jcyt.2014.01.072
Dolnikov A; Xu N; Shen S; O'Brien T, 2014, 'INCREASING STEM CELL DOSE PROMOTES THE LONGEVITY OF THE GRAFT IN MICE TRANSPLANTED WITH HUMAN CORD BLOOD STEM CELLS', in CYTOTHERAPY, ELSEVIER SCI LTD, pp. S57 - S57, http://dx.doi.org/10.1016/j.jcyt.2014.01.206
Dolnikov A; Shen S; Klamer G; Xu N; O'Brien TA, 2013, 'GSK-3 beta INHIBITION PROMOTES T CELL RECONSTITUTION AND PRESERVES NAIVE T CELL PHENOTYPE IN MICE TRANSPLANTED WITH HUMAN HAEMATOPOIETIC STEM CELLS', in CYTOTHERAPY, INFORMA HEALTHCARE, pp. S6 - S6, http://dx.doi.org/10.1016/j.jcyt.2013.01.020
Dolnikov A; Holmes T; Xu N; Shen S; Klamer G; O'Brien TA, 2013, 'TRANSIENT INHIBITION OF GSK-3,beta PROMOTES EARLY AND LATE ENGRAFTMENT OF EX VIVO EXPANDED HAEMATOPOIETIC PROGENITOR CELLS IN IMMUNO-COMPROMISED MICE', in CYTOTHERAPY, INFORMA HEALTHCARE, pp. S22 - S22, http://dx.doi.org/10.1016/j.jcyt.2013.01.081
Dolnikov A; Holmes T; Shen S; Knight R; O'Brien TA, 2006, 'N-ras(m)-transduced fibroblasts facilitate the expansion and engraftment of umbilical cord blood stem cells.', in BLOOD, AMER SOC HEMATOLOGY, Orlando, FL, pp. 912A - 912A, presented at 48th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, 09 December 2006 - 12 December 2006, http://dx.doi.org/10.1182/blood.V108.11.3196.3196
O'Brien TA; Holmes T; Vowels M; Shen S; Symonds G; Dolnikov A, 2006, 'Novel approaches for the ex vivo expansion of the engraftable cord blood derived haematopoietic progenitor cells.', in CYTOTHERAPY, TAYLOR & FRANCIS AS, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Shen S; Holmes T; Symonds G; Brien TA, 2006, 'Molecular profile and functional analysis of the molecular factors derived from ras-transduced cells that regulate hematopoiesis.', in CYTOTHERAPY, TAYLOR & FRANCIS AS, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Shen S; Symonds G; Holmes TA; O'Brien TA, 2006, 'Stroma cells support ex vivo expansion of retrovirally transduced haematopoietic progenitor cells.', in CYTOTHERAPY, INFORMA HEALTHCARE, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Holmes T; O'Brien TA; Shen S; Choo A; Symonds G; Vowels M; Dolnikov A, 2006, 'Glycogen synthase kinase-3 regulates ex vivo expansion of human umbilical cord blood progenitor cells.', in CYTOTHERAPY, TAYLOR & FRANCIS AS, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Shen S; Symonds G, 2005, 'Using a novel inhibitor of GSK-3 beta to activate the Wnt pathway in human haematopoietic stem cells: Impact on stem cell parameters', in CYTOMETRY PART A, WILEY-LISS, Queensland, AUSTRIA, pp. 415 - 416, presented at 7th Samuel A Latt Conference on Stem Cells in the Age of Fluorescence Technology, Queensland, AUSTRIA, 06 November 2005 - 09 November 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237187700065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Shen S; Symonds G, 2005, 'Ras promotes engraftment of human haematopoietic stem cells through the activation of auto/paracrine mechanisms', in CYTOMETRY PART A, WILEY-LISS, Queensland, AUSTRIA, pp. 407 - 407, presented at 7th Samuel A Latt Conference on Stem Cells in the Age of Fluorescence Technology, Queensland, AUSTRIA, 06 November 2005 - 09 November 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237187700041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Shen S; Symonds G; Dolnikov A, 2005, 'An in vivo assay for retrovirally transduced human haematopoietic stem/progenitor cells (HSC/HPC) using nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice', in JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, Melbourne, AUSTRALIA, pp. 1135 - 1135, presented at 4th Meeting of the Australasian-Gene-Therapy-Society, Melbourne, AUSTRALIA, 27 April 2005 - 29 April 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231477900072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Shen S; Passioura T; Symonds G, 2003, 'Differential retroviral transduction of primitive hematopoietic progenitors rather than gene silencing accounts for variation in transgene expression', in JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, QUEENSLAND INST MED RES BRISBANE, BRISBANE, AUSTRALIA, pp. S13 - S14, presented at 3rd Meeting of the Australasian-Gene-Therapy-Society, QUEENSLAND INST MED RES BRISBANE, BRISBANE, AUSTRALIA, 30 April 2003 - 02 May 2003, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000183493100036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Shen SW; Dolnikov A; Passioura T; Symonds G; Bradstock KF, 2002, 'Mutant N-ras induces myeloid differentiation in human cord blood CD34+ cells', in BLOOD, AMER SOC HEMATOLOGY, PHILADELPHIA, PENNSYLVANIA, pp. 209B - 209B, presented at 44th Annual Meeting of the American-Society-of-Hematology, PHILADELPHIA, PENNSYLVANIA, 06 December 2002 - 10 December 2002, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179184800888&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Abstracts
Dolnikov A; Xu N; Tse B; Shen S; O'Brien T, 2018, 'BROMODOMAIN INHIBITOR JQ1 MODULATES IMMUNE SUPPRESSIVE PATHWAYS IN NEUROBLASTOMA AND ENHANCES CARGD2T CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S97 - S97, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432441700297&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Chaudhry K; Shen S; Wang L; Bishop D; Micklethwaite K; Dolnikov A; Nordon R, 2018, 'IMAGING THE DYNAMICS OF RECEPTOR-MODIFIED T CELL EFFECTOR FUNCTION AGAINST LEUKAEMIA AND NEUROBLASTOMA TARGETS', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S103 - S103, http://dx.doi.org/10.1016/j.jcyt.2018.02.301
Bishop D; Xu N; Shen S; O'Brien T; Gottlieb D; Dolnikov A; Micklethwaite K, 2017, 'DIFFERING CO-STIMULATORY, LINKER AND SPACER DOMAINS PRODUCE VARIATIONS IN CD4 AND CD8 CELL COMPOSITION AND CYTOTOXIC POTENTIAL IN CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR19) T CELLS GENERATED WITH THE PIGGYBAC TRANSPOSASE', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 19, pp. S10 - S10, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000399265400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Yang S; Shen S; Xu N; Chaudhry K; Nordon R; O'Brien T, 2016, 'PROLONGING CART CELL PERSISTENCE USING CONDITIONING WITH 5-AZACYTIDINE', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S61 - S61, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Shen S; Xu N; Yang S; O'Brien T; Dolnikov A, 2016, 'STEM CELL APPROACH TO GENERATE CHIMERIC ANTIGEN RECEPTOR MODIFIED IMMUNE EFFECTOR CELLS TO TREAT CANCER', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S64 - S64, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Shen S; Dolnikov A; O'Brien T, 2016, 'USE OF HDACI AND PD-1/PD-LI BLOCKADE TO ENHANCE CYTOLYTIC ACTIVITY OF EX VIVO EXPANDED NK CELLS AGAINST NEUROBLASTOMA', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S64 - S64, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Klamer G; Chitranjan A; Xu N; Shen S; Micklethwaite KP; Lock RB; O'Brien T, 2014, 'Identifying the Factors Modulating the Efficacy of CAR-T Cell Therapy', in BLOOD, AMER SOC HEMATOLOGY, Vol. 124, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349242706217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolnikov A; Klamer G; Shen S; Chitranjan A; Carol H; Lock R; O'Brien T, 2014, 'IDENTIFYING THE FACTORS MODULATING THE EFFICACY OF CAR-T CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 16, pp. S7 - S7, http://dx.doi.org/10.1016/j.jcyt.2014.01.015
If you wish to be added to our mail list new SoMS staff and students are required to complete the SoMS webform as part of the data management procedure in the School. Please contact SoMS Admin soms.info@unsw.edu.au if you are a current UNSW staff or student and wish to be added to our mail list.
School of Medical Sciences - Wallace Wurth Building, UNSW Sydney NSW 2052 Australia | Contacts
© Copyright 2012 UNSW Medicine | CRICOS Provider Code: 00098G | ABN 57 195 873 179 | Authorised by Head of School of Medical Sciences